Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03793465 · ClinicalTrials.gov registry record · Phase 1
Pilot-Tart Cherry, Mitral Transcriptome, and POAF Incidence
A Phase 1 study of Post-operative Atrial Fibrillation (POAF), sponsored by University of Michigan.
- Active
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03793465 is a Phase 1 study of Post-operative Atrial Fibrillation (POAF) that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03793465, a Phase 1 study of Post-operative Atrial Fibrillation (POAF), is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess impact of Tart Cherry Concentrate in cardiac surgical patients on POAF and related clinical and economic outcomes. Measure inflammation gene transcripts in cardiac tissue.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT tart cherry concentrate
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2027-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03793465
The ClinicalTrials.gov registry entry for NCT03793465 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-operative Atrial Fibrillation (POAF) appearing as the primary indexed condition, and to 1 intervention - of which tart cherry concentrate is the first listed.
NCT03793465 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03793465 about?
NCT03793465 is a clinical study titled "Pilot-Tart Cherry, Mitral Transcriptome, and POAF Incidence". Assess impact of Tart Cherry Concentrate in cardiac surgical patients on POAF and related clinical and economic outcomes. Measure inflammation gene transcripts in cardiac tissue.
What is the current status of trial NCT03793465?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2019-02-08. Estimated completion is 2027-01.
What conditions does trial NCT03793465 study?
This clinical trial studies the following conditions: Post-operative Atrial Fibrillation (POAF).
What interventions are being tested in trial NCT03793465?
The interventions under investigation include: tart cherry concentrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03793465?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03793465 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-operative Atrial Fibrillation (POAF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.